Skip to main content

Mark Stevens

SEC CIK
0000933482
Latest filing
Oct 27, 2023

EBS holding history

Emergent BioSolutions Inc. in every 13F filed by Mark Stevens, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EBS overviewAll 13F holders of EBSFull Q3 2023 holdings

Shares (Q4 2021)
0
Sold out in Q4 2021
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2021
Holdings of EBS by Mark Stevens, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20210$00.0%−36,749−100.0%Sold outHolders
Q3 202136,749$1.84M0.2%00.0%UnchangedHolders
Q2 202136,749$2.31M0.3%00.0%UnchangedHolders
Q1 202136,749$3.41M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.